ChatDocto
Find a doctor
White scored tablet

REVOLADE 50 mg

ETROMBOPAG · film-coated tablets

B/28Oral use
See all pack prices
Strength50 mg
Therapeutic classSANG ET ORGANES HEMATOPOIETIQUES
ATC codeB02BX05

About this medicine

REVOLADE 50 mg film-coated tablets is listed in Tunisia's medicine catalog under the active ingredient ETROMBOPAG. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/28

    28 units in this pack

    Price not recorded
    AMM No.
    80833052H
    CNAM reference amount
    CNAM status to be confirmed

    Price source: No verified price source is linked to this pack.

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formfilm-coated tablets
Route of administrationOral use
LaboratoryNOVARTIS EUROPHARM LIMITED IRLANDE
OriginOriginator
ScheduleA
ATC codeB02BX05 — Eltrombopag
Therapeutic classSANG ET ORGANES HEMATOPOIETIQUES